Pharmaceutical Lifecycle Management Strategies in 2017
Comprehensive Assessment of Strategies Being Implemented by Pharmaceutical Companies Around the World - Research and Markets - Seite 2
- What are the most common LCM strategies being implemented?
- What are the business opportunities and commercial rewards arising from the implementation of LCM strategies?
- What are the key factors that impact the choice of LCM strategy?
- What strategies have Big Pharma companies implemented in recent years to preserve revenues and market share?
Key Reasons to Purchase
- Gain insights into the rationale for implementing LCM strategies, alongside their key challenges, risks and potential benefits.
- Understand the key challenges that the pharmaceutical industry has been facing in recent years
- Assess real-world examples of successful strategies implemented in the past, and the key factors that determined their success.
- Obtain information on strategies for products currently in development.
Key Topics Covered:
1. Introduction
2. Executive Summary
3. Introduction to Pharmaceutical Lifecycle Management Strategies
3.1 The Pharmaceutical Product Lifecycle Curve
3.2 Key Objectives of Life Cycle Management Strategies in the
Pharmaceutical Industry
3.3 What is Driving the Need for Effective Lifecycle Management
Strategies in the Pharmaceutical Industry?
3.4 Classification and Benefits of Different Lifecycle Management
Strategies for Pharma
3.5 Business Opportunities Created by LCM Strategies
3.6 Factors Impacting Choice of Lifecycle Strategies
4. Pharmaceutical Lifecycle Management - Commercial Strategies
4.1 Rx-to-OTC Switch as an LCM Strategy
4.1.1 RX-to-OTC Switch Case Studies
4.2 Geographical Expansion
4.3 Contract Research Organizations Helping Overcome Industry Challenges
4.3.1 Benefits from Partnering with Contract Development and
Manufacturing Organizations (CDMOs)
4.3.2 Strategic Partnerships with CROs: Case studies
4.4 Pricing and Reimbursement Strategies for LCM in Pharma
4.4.1 Key Factors and Strategies to Consider when Making Pricing
Decisions
4.4.2 Common Pricing Strategies in Pharma
4.4.3 A Systematic Value Development Plan to Achieve Optimum
Reimbursement
4.5 Customer Retention Programs as LCM Strategies for Pharma
4.5.1 Role of Medical Publications in LCM Optimization
4.6 Asset Transactions as an LCM Tactic
4.6.1 Strategic Divestitures by Type and Recent Examples
5. Regulatory and Legal Strategies
5.1 Data Exclusivity
5.2 Orphan Drug Exclusivity
5.3 Pediatric exclusivity
- Understand the key challenges that the pharmaceutical industry has been facing in recent years
- Assess real-world examples of successful strategies implemented in the past, and the key factors that determined their success.
- Obtain information on strategies for products currently in development.
Key Topics Covered:
1. Introduction
2. Executive Summary
3. Introduction to Pharmaceutical Lifecycle Management Strategies
3.1 The Pharmaceutical Product Lifecycle Curve
3.2 Key Objectives of Life Cycle Management Strategies in the
Pharmaceutical Industry
3.3 What is Driving the Need for Effective Lifecycle Management
Strategies in the Pharmaceutical Industry?
3.4 Classification and Benefits of Different Lifecycle Management
Strategies for Pharma
3.5 Business Opportunities Created by LCM Strategies
3.6 Factors Impacting Choice of Lifecycle Strategies
4. Pharmaceutical Lifecycle Management - Commercial Strategies
4.1 Rx-to-OTC Switch as an LCM Strategy
4.1.1 RX-to-OTC Switch Case Studies
4.2 Geographical Expansion
4.3 Contract Research Organizations Helping Overcome Industry Challenges
4.3.1 Benefits from Partnering with Contract Development and
Manufacturing Organizations (CDMOs)
4.3.2 Strategic Partnerships with CROs: Case studies
4.4 Pricing and Reimbursement Strategies for LCM in Pharma
4.4.1 Key Factors and Strategies to Consider when Making Pricing
Decisions
4.4.2 Common Pricing Strategies in Pharma
4.4.3 A Systematic Value Development Plan to Achieve Optimum
Reimbursement
4.5 Customer Retention Programs as LCM Strategies for Pharma
4.5.1 Role of Medical Publications in LCM Optimization
4.6 Asset Transactions as an LCM Tactic
4.6.1 Strategic Divestitures by Type and Recent Examples
5. Regulatory and Legal Strategies
5.1 Data Exclusivity
5.2 Orphan Drug Exclusivity
5.3 Pediatric exclusivity